Prokaryotics, Inc.
Antibacterial discovery organization committed to bringing forth innovative therapeutics to address AMR
Union, United States
8 employees
Unknown
Total: $2.50M
Biopharma, Biotechnology +1
General Information
Get notified when Prokaryotics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Prokaryotics, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biopharma
About Prokaryotics, Inc.
Taxonomy: antibacterial discovery, therapeutics, AMR, antibiotic resistance, biopharmaceutical, multidrug resistant bacteria, antibiotic classes, bacterial infections, outer membrane biogenesis, drug development, scientific excellence, global crisis, pre-clinical assets, Gram-negative and Gram-positive bacteria
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
01 Mar 2018 |
Prokaryotics, Inc. Alternatives & Competitors
A new era in antibiotic treatment targeting resilient gram-negative bacteria, delivering advanced or...
Pioneering orally active drugs to rejuvenate antibiotic efficacy against lung, urinary tract, and sk...
SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development...
FAQ About Prokaryotics, Inc.
Don't just browse. Track.
Signal Tracker monitors Prokaryotics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
